INTERNATIONAL PATENT: ASCLETIS PHARMA (CHINA) CO., LIMITED FILES APPLICATION FOR "2-PHENYL-1,2,4-TRIAZINE-3,5(2H,4H)-DIONE DERIVATIVES AS THR-BETA AGONIST OR MODULATORS FOR THE TREATMENT OF OBESITY"

GENEVA, April 5 -- ASCLETIS PHARMA (CHINA) CO., LIMITED (Room 1903, 19/F, Lee Garden One, 33 Hysan Avenue, Causeway Bay,Hong Kong) filed a patent application (PCT/CN2025/125429) for "2-PHENYL-1,2,4-TRIAZINE-3,5(2H,4H)-DIONE DERIVATIVES AS THR-BETA AGONIST OR MODULATORS FOR THE TREATMENT OF OBESITY" on Sep 29, 2025. With publication no. WO/2026/067791, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WU, Jinzi Jason (Room 1903, 19/F, Lee Garden One, 33 Hysan Avenue, Causeway Bay,Hong Kong), LIANG, Bin (Room 1903, 19/F, Lee ...